MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$4,221K
Free Cash flow
-$11,494K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of short-term investm...
    • Stock-based compensation
    • Accounts receivable
    • Others
Negative Cash Flow Breakdown
    • Purchases of short-term investme...
    • Net loss
    • Receivable from collaboration pa...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-12,097
-15,884
-9,152
-9,816
Depreciation and amortization
999
834
851
854
Provision for bad debts
206
0
0
0
Amortization of debt issuance costs and premium
-
-
0
-
Loss on extinguishment of debt
-
-
0
-
Amortization of right-of-use lease assets
-
0
-
0
Amortization of discount on short-term investments
1,752
1,854
1,832
2,144
Stock-based compensation
7,465
7,945
7,817
8,108
Provision for excess and obsolete inventory
1,116
60
616
66
Accounts receivable
-3,728
-936
-788
-3,907
Inventories
3,363
3,370
3,225
3,955
Receivable from collaboration partner
10,000
-
-
-
Prepaid and other assets
-1,553
-120
881
-322
Accounts payable
-631
1,577
2,204
-86
Deferred revenue - collaboration
3,500
-
-
-
Accrued expenses and other liabilities
-262
-1,255
1,698
1,557
Net cash used in operating activities
-9,538
-10,891
-1,116
-1,187
Purchases of property and equipment
1,956
759
1,137
581
Maturities of short-term investments
100,000
110,000
90,000
60,000
Purchases of short-term investments
93,392
100,393
98,477
68,423
Net cash provided by investing activities
4,652
8,848
-9,614
-9,004
Proceeds from term loan
-
-
0
-
Repayment of term loan
-
-
0
-
Proceeds from issuance of common stock from public offering
-
-
0
0
Proceeds from issuance of common stock
669
144
1,056
131
Payments for employee taxes related to stock compensation
0
-473
-2
-642
Principal payments on finance lease liabilities
7
7
-9
19
Payments of deferred offering costs
-
-
0
0
Payments of debt issuance costs
-
-
0
-
Net cash provided by financing activities
662
-336
1,063
-530
Effect of foreign exchange rate on cash, cash equivalents and restricted cash
3
3
-15
-2
Net (decrease) increase in cash, cash equivalents and restricted cash
-4,221
-2,376
-9,683
-10,723
Cash, cash equivalents and restricted cash - beginning of period
18,323
20,699
30,382
17,456
Cash, cash equivalents and restricted cash - end of period
14,102
18,323
20,699
30,382
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Maturities of short-terminvestments$100,000K (-9.09%↓ Y/Y)Proceeds from issuance ofcommon stock$669K (-75.80%↓ Y/Y)Net cash provided byinvesting activities$4,652K (-86.90%↓ Y/Y)Net cash provided byfinancing activities$662K (-50.23%↓ Y/Y)Effect of foreignexchange rate on cash,...$3K (-85.00%↓ Y/Y)Canceled cashflow$95,348K Canceled cashflow$7K Net (decrease)increase in cash, cash...-$4,221K (-117.85%↓ Y/Y)Canceled cashflow$5,317K Stock-based compensation$7,465K (-52.41%↓ Y/Y)Accounts receivable-$3,728K (-90.20%↓ Y/Y)Deferred revenue -collaboration$3,500K Prepaid and other assets-$1,553K (10.85%↑ Y/Y)Provision for excess andobsolete inventory$1,116K (-10.72%↓ Y/Y)Depreciation andamortization$999K (-36.00%↓ Y/Y)Provision for bad debts$206K (543.75%↑ Y/Y)Purchases of short-terminvestments$93,392K (29.03%↑ Y/Y)Purchases of property andequipment$1,956K (-7.39%↓ Y/Y)Principal payments onfinance lease...$7K (-56.25%↓ Y/Y)Net cash used inoperating activities-$9,538K (27.79%↑ Y/Y)Canceled cashflow$18,567K Net loss-$12,097K (39.44%↑ Y/Y)Receivable fromcollaboration partner$10,000K Inventories$3,363K (-21.83%↓ Y/Y)Amortization of discount onshort-term investments$1,752K (-61.42%↓ Y/Y)Accounts payable-$631K (57.68%↑ Y/Y)Accrued expenses andother liabilities-$262K (94.89%↑ Y/Y)

RxSight, Inc. (RXST)

RxSight, Inc. (RXST)